The MLSC and seven global biopharmaceutical companies announced on July 11, 2013, the first seven awards made to researchers through the Massachusetts Neuroscience Consortium.
The consortium was launched in June 2012 at the BIO International Convention in Boston, and the first solicitation for project submissions was issued last fall. Consortium members reviewed and evaluated nearly 100 applications and selected seven pre-clinical projects to fund at Massachusetts academic and research institutions with a focus on Alzheimer’s disease, Multiple Sclerosis, Neuropathic Pain and Parkinson’s disease. Consortium members are AbbVie, Biogen Idec, EMD Serono, Janssen Research & Development, LLC, Merck, Pfizer and Sunovion Pharmaceuticals Inc. The MLSC used its convening power to bring these companies together to form a new model for collaboration with the research community in order to accelerate the pace of discovery.